Risk Appraisal on an International Scale

  • Bruno Horisberger
  • Rolf Dinkel
Part of the Health Systems Research book series (HEALTH)


Background. A major concern for drug regulators, academic epidemiologists, and members of the pharmaceutical industry seems to be the development of a generally accepted approach to the assessment of drug-associated risks in the postmarketing phase in order to achieve safety standards that are both objective and rigorous.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Bruno Horisberger
    • 1
  • Rolf Dinkel
    • 2
  1. 1.Interdisciplinary Research Centre for Public HealthSt. GallenSwitzerland
  2. 2.HealthEcon Ltd.BaselSwitzerland

Personalised recommendations